$GOOG - Google DeepMind is positioned as the central AI engine for all of Alphabet, with Gemini models reaching billions of users across Google products, demonstrating Google's strong competitive position in AI.
$ROBOTICS - Robotics sector is approaching a breakthrough moment within the next couple of years, with potential for millions of robots to be deployed in society, significantly increasing productivity.
$PHARMA - AI will dramatically accelerate drug discovery, potentially reducing development time from years or decades down to weeks or days over the next ten years, transforming the pharmaceutical industry.
$LLY - Eli Lilly has a strong partnership with Isomorphic Labs (Google DeepMind's drug discovery company) with preclinical trials expected to begin next year, potentially accelerating their drug development pipeline.
$ENERGY - AI systems will provide net positive benefits to the energy sector through improved grid efficiency, electrical system optimization, material design innovations, and development of new energy sources, outweighing AI's own energy consumption.
$NVS - Novartis has a partnership with Isomorphic Labs that could benefit their drug discovery efforts through AI-accelerated development.